HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,391,385 | +17.8% | 46,602 | +4.7% | 0.11% | +11.0% |
| Q2 2023 | $4,576,825 | +0.7% | 44,500 | +6.8% | 0.10% | -9.1% |
| Q1 2023 | $4,546,663 | +2.0% | 41,659 | +6.3% | 0.11% | -12.0% |
| Q4 2022 | $4,457,887 | +113.0% | 39,173 | +15.8% | 0.12% | +98.4% |
| Q3 2022 | $2,093,000 | +17.3% | 33,819 | +51.2% | 0.06% | +10.5% |
| Q2 2022 | $1,784,000 | -22.2% | 22,365 | +2.6% | 0.06% | -19.7% |
| Q1 2022 | $2,293,000 | +163.6% | 21,790 | +169.8% | 0.07% | +153.6% |
| Q4 2021 | $870,000 | +15.8% | 8,076 | +17.8% | 0.03% | -6.7% |
| Q3 2021 | $751,000 | +6.8% | 6,855 | -8.7% | 0.03% | 0.0% |
| Q2 2021 | $703,000 | -84.4% | 7,508 | -84.6% | 0.03% | -85.0% |
| Q1 2021 | $4,495,000 | +203.1% | 48,833 | +140.8% | 0.20% | +308.2% |
| Q4 2020 | $1,483,000 | -22.0% | 20,279 | -71.0% | 0.05% | +44.1% |
| Q3 2019 | $1,902,000 | – | 69,852 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,462,634 | $175,978,000 | 7.18% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,221,585 | $114,954,000 | 6.73% |
| JW Asset Management, LLC | 270,775 | $7,373,000 | 6.49% |
| KOPP INVESTMENT ADVISORS LLC | 104,462 | $2,845,000 | 5.23% |
| 1492 Capital Management LLC | 171,621 | $4,673,000 | 4.56% |
| Avoro Capital Advisors LLC | 4,000,000 | $108,920,000 | 4.54% |
| Paulson & Co. | 8,170,700 | $222,488,000 | 4.46% |
| Rhenman & Partners Asset Management AB | 1,025,000 | $27,911,000 | 3.50% |
| Redwood Investments, LLC | 1,376,066 | $37,470,000 | 2.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 218,000 | $5,938,000 | 2.74% |